Results 151 to 160 of about 9,857 (174)
Some of the next articles are maybe not open access.

Ceftazidime-avibactam for the treatment of complicated intra-abdominal infections

Expert Opinion on Pharmacotherapy, 2016
The treatment of complicated intra-abdominal infections (cIAI) is increasingly challenging due to increased resistance of Gram-negative organisms. These multidrug resistant organisms lead to an increase in morbidity and mortality. This has led to renewed interest in use of older β-lactam antibiotics in combination with newer β-lactamase inhibitors ...
Sara A, Buckman   +3 more
openaire   +2 more sources

Use of Ceftazidime-Avibactam and Ceftolozane-Tazobactam After Lung Transplantation

Transplantation Proceedings, 2020
After lung transplantation (LTx), infections caused by multidrug-resistant (MDR) bacteria are frequent and difficult to treat. Some new antibiotics seem to be effective in treating these infections.We describe our experience in treatment of Klebsiella pneumoniae MDR and Pseudomonas aeruginosa MDR infections with ceftazidime-avibactam (CEF-AVI) and ...
Amore D.   +17 more
openaire   +2 more sources

Therapeutic insights: Use of ceftazidime‐avibactam in pediatric patients

Pediatrics International
Abstract Background The increasing worldwide prevalence of multidrug‐resistant (MDR) bacteria underscores the pressing demand for innovative therapeutic solutions. Ceftazidime‐avibactam (CAZ‐AVI) represents a promising new drug combination that has received approval for specific infection types.
Özge Metin Akcan   +5 more
openaire   +2 more sources

Safety evaluation of ceftazidime/avibactam based on FAERS database

Infection
To explore adverse event (AE) signals of Ceftazidime/avibactam (CZA) based on the FDA Adverse Event Reporting System (FAERS) database.AE reports primarily associated with CZA were retrieved from the FAERS database from the second quarter of 2015 to the second quarter of 2023.
Xiuhong, Zhang   +6 more
openaire   +2 more sources

Studying ceftazidime-avibactam in selected populations

The Lancet Infectious Diseases, 2016
Florian M E, Wagenlehner, Kurt G, Naber
openaire   +2 more sources

Ceftazidime and ceftazidime/avibactam

2016
Endimiani, Andrea, Wright, Hugh
openaire   +1 more source

[Single - molecule, real - time sequencing of ceftazidime - avibactam - resistant Pseudomonas aeruginosa and the mechanism of resistance to ceftazidime - avibactam].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
To perform single-molecule, real-time sequencing of ceftazidime-avibactam (CAZ-AVI)-resistant Pseudomonas aeruginosa and to investigate the mechanism underlying ceftazidime-avibactam resistance in P. aeruginosa.The susceptibility of 89 P. aeruginosa isolates randomly sampled from clinical specimens in Sanming First Hospital Affiliated to Fujian Medical
L, Wan   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy